Imagion Biosystems Limited (IBX.AX)

AUD 0.01

(-7.14%)

Total Liabilities Summary of Imagion Biosystems Limited

Imagion Biosystems Limited's latest annual total liabilities in 2023 was 8.37 Million AUD , up 58.06% from previous year.
Imagion Biosystems Limited's latest quarterly total liabilities in 2024 Q1 was 5.79 Million AUD , down -30.78% from previous quarter.
Imagion Biosystems Limited reported annual total liabilities of 5.29 Million AUD in 2022, up 554.19% from previous year.
Imagion Biosystems Limited reported annual total liabilities of 809.87 Thousand AUD in 2021, down -32.8% from previous year.
Imagion Biosystems Limited reported quarterly total liabilities of 5.79 Million AUD for 2024 Q1, down -30.78% from previous quarter.
Imagion Biosystems Limited reported quarterly total liabilities of 7.24 Million AUD for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Imagion Biosystems Limited (2023 - 2014)

Historical Annual Total Liabilities of Imagion Biosystems Limited (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	8.37 Million AUD	58.06%
2022	5.29 Million AUD	554.19%
2021	809.87 Thousand AUD	-32.8%
2020	1.2 Million AUD	-36.52%
2019	1.89 Million AUD	44.02%
2018	1.31 Million AUD	91.39%
2017	688.77 Thousand AUD	52.39%
2016	451.99 Thousand AUD	-95.32%
2015	9.65 Million AUD	123.93%
2014	4.31 Million AUD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	5.79 Million AUD	0.0%
2024 Q1	5.79 Million AUD	-30.78%
2023 Q2	7.24 Million AUD	0.0%
2023 Q1	7.24 Million AUD	36.71%
2023 Q4	8.37 Million AUD	0.0%
2023 Q3	8.37 Million AUD	15.62%
2023 FY	8.37 Million AUD	58.06%
2022 Q4	5.29 Million AUD	0.0%
2022 Q2	6.11 Million AUD	0.0%
2022 FY	5.29 Million AUD	554.19%
2022 Q3	5.29 Million AUD	-13.41%
2022 Q1	6.11 Million AUD	655.48%
2021 Q1	1.11 Million AUD	-7.33%
2021 FY	809.87 Thousand AUD	-32.8%
2021 Q2	1.11 Million AUD	0.0%
2021 Q4	809.87 Thousand AUD	0.0%
2021 Q3	809.87 Thousand AUD	-27.48%
2020 Q4	1.2 Million AUD	0.0%
2020 Q1	2.19 Million AUD	15.59%
2020 Q2	2.19 Million AUD	0.0%
2020 FY	1.2 Million AUD	-36.52%
2020 Q3	1.2 Million AUD	-45.09%
2019 Q3	1.89 Million AUD	64.87%
2019 Q1	1.15 Million AUD	-12.64%
2019 FY	1.89 Million AUD	44.02%
2019 Q2	1.15 Million AUD	0.0%
2019 Q4	1.89 Million AUD	0.0%
2018 Q3	1.31 Million AUD	29.37%
2018 Q1	1.01 Million AUD	47.94%
2018 FY	1.31 Million AUD	91.39%
2018 Q4	1.31 Million AUD	0.0%
2018 Q2	1.01 Million AUD	0.0%
2017 Q1	2.74 Million AUD	0.0%
2017 Q4	688.77 Thousand AUD	0.0%
2017 Q3	688.77 Thousand AUD	-74.9%
2017 Q2	2.74 Million AUD	0.0%
2017 FY	688.77 Thousand AUD	52.39%
2016 FY	451.99 Thousand AUD	-95.32%
2015 FY	9.65 Million AUD	123.93%
2014 FY	4.31 Million AUD	0.0%

Peer Total Liabilities Comparison of Imagion Biosystems Limited

Name	Total Liabilities	Total Liabilities Difference
Australian Clinical Labs Limited	415.29 Million AUD	97.984%
BCAL Diagnostics Limited	3.67 Million AUD	-127.737%
Genetic Signatures Limited	6.18 Million AUD	-35.419%
Genetic Technologies Limited	4.35 Million AUD	-92.243%
Healius Limited	1.94 Billion AUD	99.569%
Integral Diagnostics Limited	442.56 Million AUD	98.108%
INOVIQ Ltd	1.71 Million AUD	-387.056%
Microba Life Sciences Limited	16.82 Million AUD	50.225%
Monash IVF Group Limited	261.81 Million AUD	96.801%
Rhythm Biosciences Limited	651.54 Thousand AUD	-1185.308%
Sonic Healthcare Limited	6.75 Billion AUD	99.876%